必应词典为您提供platinum-basedchemotherapy的释义,网络释义: 化学治疗;白金类化疗药;
HemOnc Today | Cisplatin-based chemotherapy has been the standard of care formetastatic cervical cancer for about 30 years. Unfortunately, only aboutone-third of patients with cervical cancer will respond to this treatment, andresponses usually last fewer than 12 months. Moreover, cisplatin-based...
In the healthcare field, platinum compounds are a component of some chemotherapy drugs, and are also used in pacemakers and even dental fillings. The electronics industry has various applications for platinum, too — for instance, computer hard disks. From a defense standpoint, platinum has been ...
Platinum‐based chemotherapyObjective: BRCA mutations are the most frequent mutations causing homologous recombination defects in epithelial ovarian cancers (EOC). Germline mutation carriers are heterozygous for the mutation and harbor one defective allele in all cells. This has been hypothesized to cause ...
Combining Immunotherapy and Chemotherapy for Non Small Cell Lung Cancer Over the past year, the combination of platinum-based chemotherapy and immunotherapy has become the standard of care for patients with metastatic non-small... JBH Judd - 《Thoracic Surgery Clinics》 被引量: 0发表: 2020年 A ...
Chemotherapy based on platinum compounds is the standard treatment for NSCLC patients with EGFR wild type, and is also used as second line in mutated EGFR patients. Nevertheless, this therapy presents poor clinical outcomes. ERCC1, ERCC2, XRCC1, MDM2, MTHFR, MTR, and SLC19A1 gene polymorphisms...
近年来大型临床研究结果显示在4-6次的含铂(platinum based)化学治疗后给予维持性治疗可延长这些进展性非小细胞癌患者的无 … www.airitilibrary.com|基于 1 个网页 例句 释义: 全部,含铂 1. Postoperativechemotherapyschemewascombinationchemotherapythat platinum-based. ...
Nanoscale metal–organic framework with an X-ray triggerable prodrug for synergistic radiotherapy and chemotherapy. J. Am. Chem. Soc. 145, 18698–18704 (2023). Download references Acknowledgements We thank G. Zhu and J. Zhang for reagents; J. Li and M. Zhai for the 60Co source; J. Lin...
Twenty-four patients with recurrent and/or locally advanced nasopharyngeal carcinoma who received cis-platinum-based chemotherapy are reported. Twelve patients with recurrent disease previously treated with radiotherapy received cis-platinum-based chemotherapy. An overall response rate of 67% (8/12) and ...
Platinum-based adjuvant chemotherapy improves survival among patients with lung tumors, in particular non-small cell lung cancer (NSCLC). But the predicament of drug resistance in NSCLC patients is frustrating us. The profiles of microRNAs are different between platinum chemotherapy resistant and sensitiv...